The US Food and Drug Administration (FDA) has approved Oculogica’s EyeBOX, the first non-invasive, baseline-free tool directed at diagnosing concussions. It is intended for use in pediatric patients aged 5 years and in older adults aged up to 67 years.
By using eye-tracking that provides objective information, the device aids in assessing patients with suspected concussion through an easy to take, 4-minute test. With over 2.5 million emergency room visits in the United States as a result of head injuries, the device has potential to serve a large population.